New mesothelioma study finds cholesterol drug could guard against radiotherapy side effects, according to surviving mesothelioma

Scientists at Hyogo University in Japan have released their findings on the radio-protective effects of pravastatin, a drug normally used to lower cholesterol. As Surviving Mesothelioma reports in a new article, the study could have a significant impact on mesothelioma treatment in the future.